NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球數位病理市場:成長,趨勢,及預測(2019年∼2025年)

Digital Pathology Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 808302
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
全球數位病理市場:成長,趨勢,及預測(2019年∼2025年) Digital Pathology Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球數位病理市場的相關調查,市場機會和趨勢,成長及阻礙因素,各產品、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
    • 遠隔諮詢數量的增加
    • 為使實驗室的效率提高的數位病理的採用增加
    • 藥物研發及搭配診斷的用途增加
  • 阻礙因素
    • 一次診斷相關嚴格法規上的疑慮
    • 數位病理缺乏標準指南
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 掃描機
    • 軟體
    • 存儲系統
    • 其他
  • 各用途
    • 病的診斷
    • 藥物研發
    • 教育、訓練
  • 各終端用戶
    • 醫藥品,生物科技,企業,CRO
    • 醫院, 索引研究所
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • 3DHistech Ltd.
    • Definiens AG
    • HAMAMATSU PHOTONICS 株式會社
    • Leica Biosystems Nussloch GmBH
    • Mikroscan Technologies Inc.
    • Nikon Corporation
    • Olympus Corporation
    • Koninklijke Philips NV
    • Ventana Medical Systems Inc.
    • VISIONPHARM

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 52875

The increasing number of teleconsultations, rising adoption of digital pathology to enhance lab efficiency, and increasing application in drug discovery and companion diagnostics are driving the digital pathology market. Moreover, the investment in laboratory expansion and market penetration of key manufacturers are likely to propel the market growth.

Teleconsultation aims to omit geographical and functional distances between two or more geographically separated healthcare providers. It is defined as the consultation by remote telecommunications, primarily for the diagnosis or treatment of a patient at sites that are distant from the patients or primary physicians. Teleconsultation services are being implemented by several hospitals, primary healthcare physicians, private medical practices, and other medical units. Thus, it has proven to be feasible and effective, to potentially reduce costs, provide organizational benefits, and improve patient's satisfaction.

The use of digital pathology in disease diagnosis is also increasing, due to the integration of digital pathology with digital tools, barcoding, specimen tracking, and digital dictation, which improves the safety, quality, and efficiency of disease diagnoses in pathology laboratories.

The market is also expected to be driven by the increasing adoption of telepathology, rising investment in healthcare in developed countries, market penetration of key manufacturers in the developing region, and an increasing focus on drug discovery.

Key Market Trends

Disease Diagnosis is Expected to Grow the Fastest by Application, over the Forecast Period

For the diagnosis of diseases, digital pathology encompasses different technologies, which include laboratory management systems, digital dictation, dashboards and workflow management, digital image analysis, electronic specimen labeling and tracking, and synoptic reporting tools. Therefore, the integration of digital pathology, along with digital tools, barcoding, specimen tracking, and digital dictation, improves the safety, quality, and efficiency of disease diagnoses in pathology laboratories. Hence, owing to the advantages of using digital pathology for disease diagnoses, the market is expected to grow significantly, over the forecast period.

Asia-Pacific is the Fastest-growing Region and is Expected to Follow the Same Trend over the Forecast Period

The Asia-Pacific digital pathology market is anticipated to exhibit the fastest CAGR during the forecast period, due to the proliferation of advanced imaging modalities in emerging economies, growing investments in the medical field, and the presence of untapped opportunities. Thus, the presence of a large target patient population and booming healthcare industry are encouraging the growth of the regional market.

North America is expected to dominate the overall market throughout the forecast period. The presence of high per capita healthcare expenditure, increasing investment from key players, and the well-established IT and healthcare infrastructure are some of the factors contributing to the growth of the market studied in the region.

Competitive Landscape

The key players in the digital pathology market are adopting strategies, such as mergers and acquisitions, technological developments, and geographical expansions, in order to capture a significant position. Several manufacturers are focusing on developing digital pathology scanners with high throughput, improved resolution, high magnification, and high-end microscopes with automated scanning, which are expected to drive the market growth during the forecast period.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Number of Tele-consultations
    • 4.2.2 Rising Adoption of Digital Pathology to Enhance Lab Efficiency
    • 4.2.3 Increasing Application in Drug Discovery and Companion Diagnostics
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Concerns for Primary Diagnosis
    • 4.3.2 Lack of Standard Guidelines for Digital Pathology
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Scanner
    • 5.1.2 Software
    • 5.1.3 Storage Systems
    • 5.1.4 Other Products
  • 5.2 By Application
    • 5.2.1 Disease Diagnosis
    • 5.2.2 Drug Discovery
    • 5.2.3 Education and Training
  • 5.3 By End User
    • 5.3.1 Pharmaceutical, Biotechnology, Companies, and CROs
    • 5.3.2 Hospital and Reference Laboratories
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3DHistech Ltd
    • 6.1.2 Hamamatsu Photonics KK
    • 6.1.3 Leica Biosystems Nussloch GmbH
    • 6.1.4 Mikroscan Technologies Inc.
    • 6.1.5 Nikon Corporation
    • 6.1.6 Olympus Corporation
    • 6.1.7 Koninklijke Philips NV
    • 6.1.8 Ventana Medical Systems Inc.
    • 6.1.9 VISIONPHARM

7 MARKET OPPORTUNITIES AND FUTURE TRENDS